These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes. Leyden JJ Cutis; 2002 Jun; 69(6):475-80. PubMed ID: 12078851 [TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea. Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337 [TBL] [Abstract][Full Text] [Related]
8. [Bacterial resistance in acne? A meta-analysis of the controversy]. Alvarez-Sánchez M; Rodríguez-Ayala E; Ponce-Olivera RM; Tirado-Sánchez A; Arellano-Mendoza MI Cir Cir; 2016; 84(3):190-5. PubMed ID: 26738649 [TBL] [Abstract][Full Text] [Related]
9. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents. Nishijima S; Kurokawa I; Kawabata S J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531 [TBL] [Abstract][Full Text] [Related]
10. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria. Owen L; Grootveld M; Arroo R; Ruiz-Rodado V; Price P; Laird K Phytother Res; 2017 Mar; 31(3):410-417. PubMed ID: 28124400 [TBL] [Abstract][Full Text] [Related]
11. Variation in comedonal antibiotic concentrations following application of topical tetracycline for acne vulgaris. Gardner KJ; Cunliffe WJ; Eady EA; Cove JH Br J Dermatol; 1994 Nov; 131(5):649-54. PubMed ID: 7999595 [TBL] [Abstract][Full Text] [Related]
13. Effects of topical clindamycin on intestinal microflora in patients with acne. Siegle RJ; Fekety R; Sarbone PD; Finch RN; Deery HG; Voorhees JJ J Am Acad Dermatol; 1986 Aug; 15(2 Pt 1):180-5. PubMed ID: 2943760 [TBL] [Abstract][Full Text] [Related]
14. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy]. Abeck D MMW Fortschr Med; 2003 Dec; 145(51-52):29. PubMed ID: 14974325 [No Abstract] [Full Text] [Related]
15. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes. Aoki S; Nakase K; Hayashi N; Noguchi N J Med Microbiol; 2019 Jan; 68(1):26-30. PubMed ID: 30431414 [TBL] [Abstract][Full Text] [Related]
16. Effects of treatment with erythromycin 1.5 percent topical solution or clindamycin phosphate 1.0 percent topical solution on P. acnes counts and free fatty acid levels. Puhvel SM Cutis; 1983 Mar; 31(3):339-42. PubMed ID: 6220870 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne. Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195 [TBL] [Abstract][Full Text] [Related]
18. Resistance of propionibacteria to antibiotics used in the treatment of acne. Brown JM; Poston SM J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016 [TBL] [Abstract][Full Text] [Related]
19. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris. Dhawan SS Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains. Gloor M; Wasik B; Becker A; Höffler U Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]